Funding breakthrough therapies: A systematic review and recommendation von Hanna, E., Toumi, M., Dussart, C., Borissov, B., Dabbous, O., Badora, K., Auquier, P.

Volltext

PCN385 PAY-FOR-PERFORMANCE IN ONCOLOGY: A SUCCESSFUL STORY FROM BULGARIA von Borissov, B.

Volltext

PMD55 THE LEARNING CURVE AS A BARRIER IN THE CONDUCT OF RANDOMIZED CONTROLLED TRIALS WITH MEDICAL DEVICES - A LITERATURE REVIEW von Borissov, B.

Volltext

PCN232 DIVERGENT HTA DECISIONS IN EUROPE FOR ONCOLOGY DRUGS GRANTED BREAKTHROUGH DESIGNATION von Borissov, B.

Volltext

Origin, evolution and systematics of the genus Poecilimon (Orthoptera: Tettigoniidae)—An outburst of diversification in the Aegean area von Borissov, Simeon B., Heller, Klaus‐Gerhard, Çıplak, Battal, Chobanov, Dragan P.

Volltext

Evolution of Poecilimon jonicus group (Orthoptera: Tettigoniidae): a history linked to the Aegean Neogene paleogeography von Borissov, Simeon B., Bobeva, Aneliya, Çıplak, Battal, Chobanov, Dragan

Volltext

EE320 Impact of NASH Disease Model Adjustment to New Literature Findings: Assessing Cost-Effectiveness of Actual and Theoretical Treatments von Pochopien, M., Dziedzic, J., Clay, E., Aballea, S., Żerda, I., Toumi, M., Borissov, B.

Volltext

CO158 Analysis of Clinical Endpoints in Clinical Trials for NAFL and NASH: A Comprehensive Review von Pochopien, M., Dziedzic, J., Aballea, S., Clay, E., Toumi, M., Borissov, B.

Volltext

EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England von Aballea, S, Karwala, P, Zerda, I, Toumi, M, Pochopien, M, Borissov, B, Clay, E

Volltext

EE283 Cost-Effectiveness Analysis of Cell-Based Therapy for Patients with Non-Alcoholic Fatty Liver Disease von Aballea, S, Karwala, P, Zerda, I, Toumi, M, Pochopien, M, Han, R, Borissov, B, Clay, E

Volltext

PCN379 HTA ASSESSMENTS OF METASTATIC UROTHELIAL CARCINOMA TREATMENT IN EU COUNTRIES von Benisheva, T., Borissov, B., Sidzhimova, D., Atanasova, R.

Volltext

PMU9 HIGH DRUG PRICES AND THE ADEQUACY OF RETURN ON PUBLIC INVESTMENT INTO DRUG RESEARCH AND DEVELOPMENT BY THE U.S. NATIONAL INSTITUTES OF HEALTH (NIH) von Jarosławski, S., Toumi, M., Auquier, P., Borissov, B., Dussart, C.

Volltext

PMH8 PSYCHOLOGICAL ASPECTS OF GENETIC COUNSELING IN RARE GENETIC CNS DISORDERS - SHOULD REGULATORS BE MORE INVOLVED? von Jarosławski, S., Toumi, M., Auquier, P., Borissov, B., Dussart, C.

Volltext

Cost- Effectiveness of Deep Molecular Response with First- Line Nilotinib vs. Imatinib in PH+ Chronic Myeloid Leukaemia Measured by Effectively Treated Patient- Years in Bulgaria von Borissov, BN

Volltext

PSY14 - Cost- Effectiveness of Deep Molecular Response with First- Line Nilotinib vs. Imatinib in PH+ Chronic Myeloid Leukaemia Measured by Effectively Treated Patient- Years in Bu... von Borissov, BN

Volltext

Male Osteoporosis Highly Underdiagnozed in Bulgaria – A Retrospective Analysis von Borissov, BN

Volltext

PMS3 - Male Osteoporosis Highly Underdiagnozed in Bulgaria – A Retrospective Analysis von Borissov, BN

Volltext

PND108 QUALITY OF LIFE OF PATIENTS AFTER ISCHAEMIC STROKE TREATED IN A PROVINCIAL HOSPITAL IN POLAND von Jarosławski, S., Jarosławska, B., Błaszczyk, B., Toumi, M., Auquier, P., Dussart, C., Borissov, B.

Volltext

COST-EFFECTIVENESS OF EVOLOCUMAB IN TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA IN BULGARIA: MEASURING HEALTH BENEFIT BY EFFECTIVELY TREATED PATIENT-YEARS (ETPY) von Borissov, B, Urbich, M, Georgieva, B, Tsenov, S, Villa, G

Volltext

European Experiences of Cross-Border Collaboration in Procurement of Health Technologies von Achour, L, Chachoua, L, Hanna, E, Borissov, BN, Toumi, M

Volltext